Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against TG Therapeutics, Inc.
OKLAHOMA CITY--(BUSINESS WIRE)--Nov 19, 2018--On October 4, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York against TG Therapeutics, Inc. (NASDAQ: TGTX). Federman & Sherwood reminds current and former shareholders of TG Therapeutics, Inc. that they only have until Monday, December 3, 2018 to move the court for appointment as a lead plaintiff in this case. The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.
If you purchased TG Therapeutics, Inc. shares between June 4, 2018 and September 25, 2018, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please contact our office as soon as possible. Our firm seeks to recover damages on behalf of the Class. Federman & Sherwood has extensive experience and expertise in prosecuting securities litigation involving financial fraud. We represent investors throughout the country in shareholder litigation.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181119005600/en/
CONTACT: William B. Federman
FEDERMAN & SHERWOOD
(405) 235-1560/Fax: (405) 239-2112
KEYWORD: UNITED STATES NORTH AMERICA OKLAHOMA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL
SOURCE: Federman & Sherwood
Copyright Business Wire 2018.
PUB: 11/19/2018 11:49 AM/DISC: 11/19/2018 11:49 AM